MetLife Investment Management LLC Purchases New Shares in Stevanato Group S.p.A. $STVN

Key Points

• MetLife Investment Management LLC purchased 633,887 shares of Stevanato Group S.p.A., valued at approximately $12.9 million, representing about 0.21% of the company's stock.
• Several institutional investors have increased their stakes in Stevanato Group, with notable increases from T. Rowe Price (13.3% increase) and Raymond James Financial (77.4% increase).
• Wall Street analysts maintain a generally positive outlook, with an average rating of "Moderate Buy" and one analyst giving a "Strong Buy" rating for Stevanato Group's stock.

MetLife Investment Management LLC acquired a new position in Stevanato Group S.p.A. (NYSE:STVN - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 633,887 shares of the company's stock, valued at approximately $12,944,000. MetLife Investment Management LLC owned about 0.21% of Stevanato Group at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Whittier Trust Co. acquired a new stake in shares of Stevanato Group in the first quarter worth $27,000. Johnson Financial Group Inc. acquired a new stake in shares of Stevanato Group in the fourth quarter worth $41,000. SVB Wealth LLC acquired a new stake in shares of Stevanato Group in the first quarter worth $46,000. Van Berkom & Associates Inc. grew its stake in shares of Stevanato Group by 33.3% in the first quarter. Van Berkom & Associates Inc. now owns 2,400 shares of the company's stock worth $49,000 after acquiring an additional 600 shares during the last quarter. Finally, Wells Fargo & Company MN boosted its stake in Stevanato Group by 680.3% during the fourth quarter. Wells Fargo & Company MN now owns 3,246 shares of the company's stock worth $71,000 after buying an additional 2,830 shares in the last quarter.

Analyst Ratings Changes

Separately, William Blair reiterated an "outperform" rating on shares of Stevanato Group in a research note on Monday, June 30th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy".

Stevanato Group Price Performance

Shares of NYSE STVN traded down €0.32 during midday trading on Friday, reaching €23.14. 254,200 shares of the company traded hands, compared to its average volume of 337,636. The firm has a market cap of $7.01 billion, a PE ratio of 42.85, a PEG ratio of 2.21 and a beta of 0.55. The stock's 50-day simple moving average is €24.22 and its 200-day simple moving average is €22.50. Stevanato Group S.p.A. has a 12 month low of €17.12 and a 12 month high of €28.00. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.22 and a current ratio of 1.79.

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.